Locally Advanced Oral Cavity Squamous Cell Carcinoma: Clinical Trials

5 trials for Locally Advanced Oral Cavity Squamous Cell Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 not yet recruiting. 2 Phase 1, 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Recruiting 1
Phase 22Completed 1, Not yet recruiting 1
Phase 31Recruiting 1

Follow Locally Advanced Oral Cavity Squamous Cell Carcinoma: new trials by email Literature Review of Locally Advanced Oral Cavity Squamous Cell Carcinoma trials Research Report on Locally Advanced Oral Cavity Squamous Cell Carcinoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Proton Spatially Fractionated Radiotherapy or Photon Stereotactic Body Radiotherapy in Combination With Pembrolizumab Before Surgery for the Treatment of Locally Advanced and Radiation-Naive Locoregionally Recurrent Oral Cavity Cancer, OSPRI Trial
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Locally Advanced Oral Cavity Squamous Cell Carcinoma, Locally Recurrent Oral Cavity Squamous Cell Carcinoma
Phase 2Not yet recruitingMayo Clinic302026-09-072026-08-25
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Advanced Head and Neck Cancer Who Cannot Receive Cisplatin
Biospecimen Collection, Carboplatin, Cetuximab - Locally Advanced Hypopharyngeal Squamous Cell Carcinoma, Locally Advanced Laryngeal Squamous Cell Carcinoma
Phase 3RecruitingNRG Oncology4542026-07-312026-10-27
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Biopsy Procedure, Biospecimen Collection, Cisplatin - Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Phase 1RecruitingNational Cancer Institute (NCI)462022-09-192026-09-22
Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer
Proton Beam Radiation Therapy, Quality-of-Life Assessment, Questionnaire Administration - Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced Hypopharyngeal Squamous Cell Carcinoma
Phase 1CompletedM.D. Anderson Cancer Center32020-10-192024-10-29
Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin
Cisplatin, Hearing Handicap Inventory for Adults - Screening, Radiation Therapy - Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Phase 2CompletedHyunseok Kang, MD162020-10-142024-06-28

Narrower conditions

Carcinoma (3)  ·  Hypopharyngeal Neoplasms (3)  ·  Laryngeal Neoplasms (3)  ·  Mouth Neoplasms (2)  ·  Oropharyngeal Neoplasms (2)  ·  Nasopharyngeal Carcinoma (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Broader conditions

Head and Neck Neoplasms (4)  ·  Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms by Site (4)  ·  Neoplasms, Glandular and Epithelial (4)  ·  Laryngeal Diseases (3)  ·  Otorhinolaryngologic Diseases (3)  ·  Otorhinolaryngologic Neoplasms (3)  ·  Pharyngeal Diseases (3)  ·  Pharyngeal Neoplasms (3)  ·  Respiratory Tract Diseases (3)  ·  Respiratory Tract Neoplasms (3)  ·  Stomatognathic Diseases (3)  ·  Mouth Diseases (2)  ·  Carcinoma (1)

Interventions

Magnetic Resonance Spectroscopy (3)  ·  Specimen Handling (3)  ·  1,2-diaminocyclohexaneplatinum II citrate (2)  ·  Biopsy (2)  ·  Cisplatin (2)  ·  Radiation (2)  ·  Radiotherapy (2)  ·  (225)Ac-DOTA-c(RGDyK) (1)  ·  Carboplatin (1)  ·  Cetuximab (1)  ·  Paclitaxel (1)  ·  Platinum (1)  ·  Proton Therapy (1)  ·  Protons (1)  ·  Radiotherapy, Intensity-Modulated (1)

Sponsors

Hyunseok Kang, MD (1)  ·  M.D. Anderson Cancer Center (1)  ·  Mayo Clinic (1)  ·  NRG Oncology (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (5)  ·  Canada (1)

Top investigators

Clifton D Fuller (1)  ·  Daniel K. Ebner, MD, MPH (1)  ·  Hyunseok Kang, MD (1)  ·  Loren K Mell (1)  ·  Malcolm D Mattes (1)

Results publications

PMID 34841093

NIH funding

U10CA180868 (1), UM1CA186644 (1)